SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,112,538,962 |
| Positions | 27 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | DNTH | COM | $179,525,699 | 1,841,667 |
| DEFINIUM THERAPEUTICS INC | DFTX | COM SHS | $138,768,000 | 2,950,000 |
| ABIVAX SA | ABVX | SPONSORED ADS | $132,327,180 | 993,000 |
| COGENT BIOSCIENCES INC | COGT | COM | $90,945,000 | 2,350,000 |
| ALUMIS INC | ALMS | COM | $79,655,898 | 2,830,700 |
| ARRIVENT BIOPHARMA INC | AVBP | COM | $68,474,416 | 1,971,054 |
| TAYSHA GENE THERAPIES INC | TSHA | COM SHS | $66,010,992 | 9,693,244 |
| BIOAGE LABS INC | BIOA | COM | $42,843,480 | 1,748,000 |
| MIRUM PHARMACEUTICALS INC | MIRM | COM | $39,675,023 | 338,900 |
| KYMERA THERAPEUTICS INC | KYMR | COM | $35,547,700 | 310,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.